Christopher D. Roberts's most recent trade in Black Diamond Therapeutics Inc was a trade of 2,500 Common Stock done at an average price of $26.6 . Disclosure was reported to the exchange on May 3, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Black Diamond Therapeutics Inc | Christopher D. Roberts | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 26.64 per share. | 03 May 2021 | 2,500 | 3,200 (0%) | 0% | 26.6 | 66,602 | Common Stock |
| Black Diamond Therapeutics Inc | Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2021 | 2,500 | 163,609 | - | - | Stock Option (Right to Buy) | |
| Black Diamond Therapeutics Inc | Christopher D. Roberts | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.86 per share. | 03 May 2021 | 2,500 | 5,700 (0%) | 0% | 10.9 | 27,150 | Common Stock |